lower acetylcholine concentrations than those required to contract smooth muscle.2-4 With high agonist concentrations, direct constrictor effects tend to supersede endothelium-dependent relaxation. Accordingly, muscarinic effects on vasomotor regulation cannot be adequately characterized using only one or two arbitrary doses of acetylcholine.
The balance between two opposing muscarinic effects, endothelium-mediated vasodilation and direct stimulation of smooth muscle, appears to provide a satisfactory explanation for the variable vasomotor effects of acetylcholine. There are still unanswered questions, however. First, there is evidence that neurogenic muscarinic vasodilation may occur as an endothelium-independent event.8 Second, it is difficult to envision how acetylcholine released in quantal amounts from adventitial nerves can reach endothelial cells. Perhaps transmural diffusion of neurotransmitter is operative mainly at the level of thin-walled arterioles. Alternatively, muscarinic agonists might originate from nonneural sources.9 Third, the regulation of muscarinic receptors is still poorly characterized. Five muscarinic receptors have been cloned already, and selective agonists and antagonists are not available to differentiate them in intact tissues.10 Fourth, endothelial cells release in addition to EDRF multiple vasoactive agents with both constrictor and dilator effects.3 Possible interactive regulatory mechanisms between EDRF and these agents remain to be delineated.
In 1984, we reported that arteries isolated from rabbits with diet-induced hypercholesterolemia exhibited a defective endothelium-dependent relaxation in response to acetylcholine.1112 We showed in such rabbits that acetylcholine was ineffective in reducing hindlimb total vascular resistance. 13 We were then able to demonstrate by video-microscopic visualization of skeletal muscle microvessels in situ that arterioles (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) studies in which patients with variant angina were challenged with parasympathetic (methacholine) and sympathetic (epinephrine) agonists. They suggested that enhanced activity of the parasympathetic nervous system was involved in initiating attacks of variant angina. Subsequently, they injected 10-80 ,ug acetylcholine into coronary arteries of patients with variant angina and concluded that this maneuver was useful for the diagnostic provocation of coronary spasm.20
They then extended their studies to patients with coronary disease not suffering from variant angina and found that acetylcholine (30-100 gg i.c.) induced coronary constriction in many patients with "normal or almost normal' coronary arteries, although other patients with similar angiographic anatomy responded with diffuse dilation.2' Furthermore, they emphasized that vasomotor responses along the segments of single coronary arteries were nonuniform. They proposed that angiographically normalappearing arteries constrict in response to acetylcholine because of a dysfunctional endothelium in arterial segments without appreciable angiographic changes. 21 In the present issue of Circulation,22 Yasue and collaborators have extended their observations on muscarinic coronary reactivity. They performed selective coronary arteriography in 74 patients, 49 of whom were diagnosed as having "normal smooth coronary arteries." These patients were subdivided into subjects younger and older than 30 years, but one does not know how the authors arrived at this arbitrary age limit. In the younger group, acetylcholine (50 ,ug i.c.) evoked coronary dilation that was most prominently expressed in distal coronary segments, but in the older group the preponderant response was constriction. In 29 patients exhibiting coronary luminal irregularities and stenoses, acetylcholine elicited only constrictor responses. Nitroglycerin was an efficacious dilator in all groups. Coronary risk factors, including a total plasma cholesterol of more than 240 mg/dl, arterial pressure of more than 160/90 mm Hg, and tobacco smoking, were less prevalent in young patients and most prevalent in the group with coronary disease. The authors made no attempt to analyze possible associations between coronary reactivity and individual risk factors. Also, data on the dose-dependency of the muscarinic effects were not presented. Yasue and collaborators conclude that patients more than 30 years old who have angiographically normal coronary arteries tend to have endothelial dysfunction or atherosclerosis.
In another article in this issue of Circulation, Vita et a123 have attempted to determine possible relations between coronary responses to intracoronary acetylcholine and coronary risk factors. During a 52-month period, they studied the response of intracoronary acetylcholine in 106 patients. It is not explained how the patients were selected for these studies. Thirtyfour patients were singled out for further evaluation because their angiograms revealed "entirely smooth coronary arteries, without stenoses or even minimal luminal irregularities." Graded infusions of acetylcholine into the left anterior descending coronary artery were estimated to have produced final "intracoronary concentrations" of 0.01, 0.1, and 1.0 ,uM, but eight patients received only two of the three infusions. Computer-assisted quantitative arteriography was used to determine average percent changes in arterial diameter for the different acetylcholine doses were calculated. Data points for the different acetylcholine concentrations were used to determine slopes of the dose-response effects, positive and negative slopes indicating dilation and constriction, respectively. A multiple stepwise regression analysis was interpreted as showing independent associations between acetylcholine responses and coronary risk factors including total serum cholesterol, family history, and gender. The authors conclude that the development of muscarinic constrictor responses are likely to be an abnormality of endothelial function and a precursor of angiographically detectable coronary disease.
In conclusion, the two studies are in apparent agreement with experimental data indicating that hypercholesterolemia may be associated with impaired endothelial function. 
